The use of fibrinogen concentrate for the management of trauma-related bleeding: A systematic review and meta-analysis

Blood Transfusion

Volumn 15, Issue 4, 2017, Pages 318-324

  Mengoli, Carlo ^a   Franchini, Massimo ^a,b   Marano, Giuseppe ^a   Pupella, Simonetta ^a   Vaglio, Stefania ^a,c   Marietta, Marco ^d   Liumbruno, Giancarlo M ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CARLO POMA HOSPITAL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Bleeding; Fibrinogen concentrate; Mortality; Trauma

Indexed keywords

FIBRINOGEN CONCENTRATE; FIBRINOGEN;

BLEEDING; BLOOD CLOTTING PARAMETERS; CLINICAL OUTCOME; ERYTHROCYTE TRANSFUSION; HOSPITAL MORTALITY; HUMAN; INCIDENCE; INJURY; META ANALYSIS; MULTIPLE ORGAN FAILURE; POSTTRAUMATIC COMPLICATION; REVIEW; SYSTEMATIC REVIEW; THROMBOCYTE TRANSFUSION; THROMBOEMBOLISM; DISEASE FREE SURVIVAL; FEMALE; INJURY SCALE; MALE; MORTALITY; SURVIVAL RATE;

DISEASE-FREE SURVIVAL; FEMALE; FIBRINOGEN; HEMORRHAGE; HUMANS; MALE; SURVIVAL RATE; TRAUMA SEVERITY INDICES; WOUNDS AND INJURIES;

EID: 85021820346     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2017.0094-17     Document Type: Review

References (43)

1. Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care 2016; 20: 100.
2. Cothren CC, Moore EE, Hedegaard HB, Meng K. Epidemiology of urban trauma deaths: a comprehensive reassessment 10 years later. World J Surg 2007; 31: 1507-11.
3. Frith D, Goslings JC, Gaarder C, et al. Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations. J Thromb Haemost 2010; 8: 1919-25.
4. Floccard B, Rugeri L, Faure A, et al. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury 2012; 43: 26-32.
5. Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma 2008; 65: 748-54.
6. Noel P, Cashen S, Patel B. Trauma-induced coagulopathy: from biology to therapy. Semin Hematol 2013; 50: 259-69.
7. Maegele M, Schöchl H, Cohen MJ. An update on the coagulopathy of trauma. Shock 2014; 41: S21-5.
8. Maegele M, Nardi G, Schöchl H. Hemotherapy algorithm for the management of trauma-induced coagulopathy: the German and European perspective. Curr Opin Anaesthesiol 2017; 30: 257-64.
9. Franchini M, Lippi G. Fibrinogen replacement therapy. A critical review of the literature. Blood Transfus 2012; 10: 23-7.
10. Schlimp CJ, Schöchl H. The role of fibrinogen in trauma-induced coagulopathy. Hamostaseologie 2014; 34: 29-39.
11. Hiippala ST, Myllylä GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81: 360-5.
12. Rourke C, Curry N, Khan S, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012; 10: 1342-51.
13. Mosesson MW. Fibrinogen and fibrin structure and function. J Thromb Haemost 2005; 3: 1894-904.
14. Levy JH, Welsby I, Goodnough LT. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion 2014; 54: 1389-405.
15. Vaglio S, Prisco D, Biancofiore G, et al. Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults. Blood Transfus 2016; 14: 23-65.
16. Liumbruno GM, Bennardello F, Lattanzio A, et al. Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Working Party. Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period. Blood Transfus 2011; 9: 19-40.
17. Liumbruno GM, Bennardello F, Lattanzio A, et al. Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Working Party. Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period. Blood Transfus 2011; 9: 189-217.
18. Liumbruno GM, Bennardello F, Lattanzio A, et al. Italian Society of Transfusion Medicine and Immunohaematology Working Party. Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period. Blood Transfus 2011; 9: 320-35.
19. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30: 270-382.
20. Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013; 17: R76.
21. Fries D, Innerhofer P, Perger P, et al. [Coagulation management in trauma-related massive bleeding-recommendations of the Task Force for Coagulation (AGPG) of the Austrian Society of Anesthesiology, Resuscitation and Intensive Care Medicine (OGARI).] Anasthesiol Intensivmed Notfallmed Schmerzther 2010; 45: 552-61. [In German.]
22. Schochl H, Schlimp CJ, Voelckel W. Potential value of pharmacological protocols in trauma. Curr Opin Anesthesiol 2013; 26: 221-9.
23. Meyer MA, Ostrowski SR, Windelov NA, Johansson PI. Fibrinogen concentrate for bleeding trauma patients: what is the evidence? Vox Sang 2011; 101: 185-90.
24. Maegele M, Zinser M, Schlimp C, et al. Injectable hemostatic adjuncts in trauma: fibrinogen and the FIinTIC study. J Trauma Acute Care Surg 2015; 78: S76-82.
25. Nascimento B, Callum J, Tien H, et al. Fibrinogen in the initial resuscitation of severe trauma (FiiRST): a randomized feasibility trial. Br J Anaesth 2016; 117: 775-82.
26. Steinmetz J, Sørensen AM, Henriksen HH, et al. Pilot randomized trial of fibrinogen in trauma haemorrhage (PRooF-iTH): study protocol for a randomized controlled trial. Trials 2016; 17: 327.
27. Liumbruno GM, Vaglio S, Capuzzo E, Franchini M. Fibrinogen concentrate as haemostatic therapy in acquired bleeding disorders: not only a question of dosing strategies and thresholds. Blood Transfus 2015; 13: 159-60.
28. Danes AF, Cuenca LG, Bueno SR, et al. Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Vo x Sang 2008; 94: 221-6.
29. Schochl H, Nienaber U, Hofer G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14: R55.
30. Schochl H, Nienaber U, Maegele M, et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15: R83.
31. Weiss G, Lison S, Glaser M, et al. Observational study of fibrinogen concentrate in massive hemorrhage: evaluation of a multicenter register. Blood Coagul Fibrinolysis 2011; 22: 727-34.
32. Nienaber U, Innerhofer P, Westermann I, et al. The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion. Injury 2011; 42: 697-701.
33. Innerhofer P, Westermann I, Tauber H, et al. The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury 2013; 44: 209-16.
34. Wafaisade A, Lefering R, Maegele M, et al. Administration of fibrinogen concentrate in exsanguinating trauma patients is associated with improved survival at 6 hours but not at discharge. J Trauma Acute Care Surg. 2013; 74: 387-93.
35. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-6.
36. Zentai C, Grottke O, Spahn DR, Rossaint R. Nonsurgical techniques to control massive bleeding. Anesthesiol Clin 2013; 31: 41-53.
37. Levy JH, Szlam F, Tanaka KA, Sniecienski RM. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg 2012; 114: 261-74.
38. Winearls J, Campbell D, Hurn C, et al. Fibrinogen in traumatic haemorrhage: a narrative review. Injury 2017; 48: 230-42.
39. Lunde J, Stensballe J, Wikkelso A, et al. Fibrinogen concentrate for bleeding: a systematic review. Acta Anaesthesiol Scand 2014; 58: 1061-74.
40. Marano G, Mengoli C, Franchini M, et al. Fibrinogen concentrate in surgery. Blood Transfus 2017; 15: 215-7.
41. Poole D. Coagulopathy and transfusion strategies in trauma. Overwhelmed by literature, supported by weak evidence. Blood Transfus 2016; 14: 3-7.
42. Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23-32.
43. Franchini M, Mannucci PM. Adjunct agents for bleeding. Curr Opin Hematol 2014; 21: 503-8.